Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Gut hormone

Gastrin

Gastrin is a peptide hormone released by G-cells of the gastric antrum that stimulates acid secretion from the stomach's parietal cells.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.

Length
n/a
Class
Gut hormone
Function
Stimulates gastric acid secretion and gastric mucosal growth
Context
Endogenous hormone; central to acid-physiology and Zollinger–Ellison research

The master driver of stomach-acid secretion — and a shared receptor with CCK.

Also known as: gastrin-17 · gastrin-34

Part of the Metabolic & GLP-1 peptides cluster

Overview

Gastrin is a peptide hormone released by G-cells of the gastric antrum that stimulates acid secretion from the stomach's parietal cells. Circulating in several lengths such as gastrin-17 and gastrin-34, it is a foundational hormone in digestive physiology and in the study of acid-related disorders.

Source & context

Biological / chemical source: G-cells of the stomach antrum and duodenum

Primary research or clinical context: Endogenous hormone; central to acid-physiology and Zollinger–Ellison research

Structure and the CCK connection

Gastrin and cholecystokinin share the same C-terminal amidated pentapeptide, so they can act on overlapping receptors — gastrin works mainly through the CCK-B (CCK-2) receptor. The mature hormone also carries a sulfated tyrosine and circulates as multiple processed forms, illustrating peptide-family relatedness through shared motifs.

Physiology and clinical relevance

By driving parietal-cell acid output and mucosal growth, gastrin sits at the center of digestive physiology. Excess gastrin, as in gastrinoma (Zollinger–Ellison syndrome), is a classic teaching example. Coverage here is educational and describes hormone biology rather than diagnosis or treatment.

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.

Molecular form
Gastrin (source record; form not independently established)
Species
Not established by this molecular identity audit
Termini (N / C)
Not specified / Not specified

Average reference mass

Reference policy updated: 2026-10-05

Molecular formula
C97H126N20O32S
Average reference mass
≈ 2,116.2
Identifiers

Chemistry values: PubChem, IUPHAR/BPS Guide to Pharmacology · fetched 2026-10-01.

Clinical development snapshot

ClinicalTrials.gov lists 61 registered studies with “Gastrin” as an intervention (snapshot 2026-10-01). A registry footprint is not evidence of efficacy or approval.

Registered studies
61
Highest phase reached
Phase 4
Active in latest 100
14
Most recent update
2026-09-22
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT06379217NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy inPhase 1active not recruiting2026-09-22
NCT07828678PET/CT Imaging of GRPR Expression in Various TumorsEarly phase 1not yet recruiting2026-09-18
NCT05870579[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ AdvancPhase 1active not recruiting2026-09-11
NCT06247995A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in PatienPhase 2active not recruiting2026-09-11
NCT00702533A New Method for Determining Gastric Acid Output Using a Wireless Capsule—completed2026-08-31
NCT05889728Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast CancerPhase 2completed2026-08-19
See all on ClinicalTrials.gov →
Concentration math

Gastrin — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: Gastrin (source record; form not independently established)Average reference mass: 2,116.2 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the Gastrin calculator on its own page →

Change log

Dated observations from the data pipeline (registry flags, trial footprints, identifiers) and editorial reviews of this profile.

  1. Trials1 registered study added on ClinicalTrials.gov (now 61).

FAQ about Gastrin

What is Gastrin?+

Gastrin is a peptide hormone released by G-cells of the gastric antrum that stimulates acid secretion from the stomach's parietal cells. Circulating in several lengths such as gastrin-17 and gastrin-34, it is a foundational hormone in digestive physiology and in the study of acid-related disorders.

What Canadian product status is recorded for Gastrin?+

Canadian product status for Gastrin has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the typical length of Gastrin?+

Gastrin is not a classic amino-acid chain peptide in the same sense; see the profile for classification details.

Related peptides

References & further reading

  1. 1.Gemelli et al. (1987). Gastrin 17 and gastrin 34, before and after a meal, in newborn infants. J Pediatr Gastroenterol Nutr
  2. 2.Xiang et al. (2025). Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head-To-Head Comparison of Lateral Flow and Enzyme-Linked Immunosorbent Assays. Helicobacter
  3. 3.Rehfeld et al. (2007). The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem
  4. 4.Rehfeld et al. (1976). The heterogeneity of gastrin, with reference to conversion of gastrin-17. Clin Endocrinol (Oxf)
  5. 5.Huang et al. (1989). Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides
  6. 6.Chen et al. (2000). Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice. Gastroenterology
  7. 7.Copps et al. (2009). The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers. Protein Pept Lett
  8. 8.Lee et al. (2025). A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels. Gut Liver
  9. 9.PubChem — compound summary for Gastrin (CID 44288444)
  10. 10.Wikipedia — Gastrin
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Gastrin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.